Last Updated: November 8, 2026

Details for New Drug Application (NDA): 020398

NDA 020398 describes PROPULSID, which is a drug marketed by Janssen Pharms and Janssen Pharma and is included in three NDAs. Additional details are available on the PROPULSID profile page.

The generic ingredient in PROPULSID is cisapride monohydrate. There is one drug master file entry for this compound. Additional details are available on the cisapride monohydrate profile page.

Summary for 020398

Tradename:	PROPULSID
Applicant:	Janssen Pharms
Ingredient:	cisapride monohydrate
Patents:	0

Medical Subject Heading (MeSH) Categories for 020398

Anti-Ulcer Agents
Gastrointestinal Agents
Serotonin Receptor Agonists

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	SUSPENSION;ORAL			Strength	EQ 1MG BASE/ML
Approval Date:	Sep 15, 1995	TE:		RLD:	No

Expired US Patents for NDA 020398

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Janssen Pharms	PROPULSID	cisapride monohydrate	SUSPENSION;ORAL	020398-001	Sep 15, 1995	4,962,115	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.